Contributors | |
Preface | |
Overview: an introduction to NASH and related fatty liver disorders | |
Pathology of hepatic steatosis, NASH and related conditions | |
The epidemiology and risk factors of NASH | |
Insulin resistance in NAFLD: potential mechanisms and therapies | |
NASH as part of the metabolic (insulin resistance) syndrome | |
NASH is a genetically determined disease | |
The pathogenesis of NASH: human studies | |
Animal models of steatohepatitis | |
Fatty acid metabolism and lipotoxicity in the pathogenesis of NAFLD/NASH | |
Cytokines and inflammatory recruitment in NASH: experimental and human studies | |
Mitochondrial injury and NASH | |
Cell biology of NASH: fibrosis and cell proliferation | |
Clinical manifestations and diagnosis of NAFLD | |
The clinical outcome of NAFLD including cryptogenic cirrhosis | |
Practical approach to the diagnosis and management of people with fatty liver diseases | |
Management of NASH: current and future perspectives on treatment | |
NAFLD, NASH and orthotopic liver transplantation | |
NAFLD/NASH is not just a æWesternÆ problem: some perspectives on NAFLD/NASH from the East | |
NAFLD/NASH in children | |
Steatohepatitis resulting from intestinal bypass | |
Specific disorders associated with NAFLD | |
Hepatocellular carcinoma in NAFLD | |
Does NASH or NAFLD contribute to comorbidity of other liver diseases? | |
Recent advances | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.